← Back to all trials
Enrolling By Invitation
NCT05689177
Humoral Immunity Study After a Booster Dose of Soberana Plus (FINLAY-FR-1A) Vaccine Against COVID-19
Conditions: Humoral Immunity
Sex: All
Ages: 18 Years – 80 Years
Healthy volunteers: 1
Phase: NA
Enrollment: 100
Sponsor: Gomel State Medical University
Location: Belarus
Summary
To evaluate the dynamics of IgG levels to the SARS-CoV-2 virus after a booster dose of Soberana Plus vaccine.
Eligibility Criteria
Inclusion Criteria:Age 18-80 y.o.;More that 4 months after the previous vaccination against COVID-19;No COVID-19 infection registered within 30 days prior to Soberana Plus administration.Exclusion Criteria:Age less than 18 y.o. or more than 80 y.o.;Less than 4 months after the previous vaccination against COVID-19;COVID-19 infection registered within 30 days prior to Soberana Plus administration.
Source: ClinicalTrials.gov (NCT05689177). StuddyBuddy aggregates publicly available trial information.
